View drug registration information details.
Items | Registration information |
ID | 2201 |
No | 2201 |
Brand Name | METHARAN N |
Ingredients | BETAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V, NEOMYCINE SULFATE BP 0.5 %W/V,THIOMERSAL BP 0.005 % W/V |
Dosage Form | SOLUTION |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | 10 ML/BOTTLE/CARTON |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | EYE: SHORT TERM TREATMENT OF STEROID RESPONSIVE INFLAMMATORY, EAR: OTITIS EXTERNA OR OTHER STEROID RESPONSIVE, NOSE: STEROID RESPONSIVE INFLAMMATORY CONDITIONS WHERE PROPHYLACTIC ANTIBIOTIC TREATMENT IS ALSO REQUIRED |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | CLEAR COLORLESS TO YELLOWISH LIQUID FILLED IN WHITE PLASTIC BOTTLE |
Note | |
License Owner | POUNSAB PHARMA CO.,LTD |
Manufacturer | BRAWN LABORATORIES LIMITED |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 I 4672/19 |
FDD Registration Date | 06-DEC-2022 |
Expiry Date | 05-DEC-2025 |
Back to drug list
|